Form 10 Explorer
10-Q
Quarterly Report
BIO KEY INTERNATIONAL INC

BKYI

NASDAQ

CIK: 1019034

File #: 1-13463

Period End: Sep 30, 2024

Fiscal Year: 2024

View on EDGAR
Balance Sheet
40 line items · 2 periods
XBRL
ItemSep 30, 2024Dec 31, 2023
ASSETS
Cash and cash equivalents
1,801,137511,400
Accounts receivable, net
1,930,2581,201,526
Due from factor
49,01899,320
Inventory
386,944445,740
Prepaid expenses and other
382,866364,171
Total current assets
4,550,2232,622,157
Equipment and leasehold improvements, net
162,551220,177
Capitalized contract costs, net
430,596229,806
Deposits and other assets
7,9750
Operating lease right-of-use assets
73,63736,905
Approximation
73,63636,905
Intangible assets, net
1,174,7211,407,990
Total non-current assets
1,849,4801,894,878
TOTAL ASSETS
6,399,7034,517,035
LIABILITIES
Accounts payable
1,564,6541,316,014
Accrued liabilities
1,254,4151,305,848
Senior Secured Promissory Note
2,164,6930
Government Loan
141,854138,730
Deferred revenue, current
719,846414,968
Operating lease liabilities, current portion
24,54537,829
Total current liabilities
5,870,0073,213,389
Deferred revenue, long term
240,66428,296
Deferred tax liability
22,99822,998
Government loan – BBVA Bank – net of current portion
83,901188,787
Operating lease liabilities, net of current portion
49,0910
Total non-current liabilities
396,654240,081
TOTAL LIABILITIES
6,266,6613,453,470
STOCKHOLDERS’ EQUITY
Common stock — authorized, 170,000,000 shares; issued and outstanding; 3,109,288 and 1,032,777 of $.0001 par value at September 30, 2024 and December 31, 2023, respectively
311103
Additional paid-in capital
127,981,436126,047,851
Accumulated other comprehensive loss
74,69922,821
Accumulated deficit
(127,923,404)(125,007,210)
TOTAL STOCKHOLDERS’ EQUITY
133,0421,063,565
Common Stock
311103
Additional Paid-in Capital
127,981,436126,047,851
AOCI Attributable to Parent
74,69922,821
Retained Earnings
(127,923,404)(125,007,210)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
6,399,7034,517,035